Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Haanen JB"'
Autor:
Chapman, Pb, Hauschild, A, Robert, C, Haanen, Jb, Ascierto, P, Larkin, J, Dummer, R, Garbe, C, Testori, A, Maio, M, Hogg, D., Lorigan, P, Lebbe, C, Jouary, T, Schadendorf, D, Ribas, A, O'Day, Sj, Sosman, Ja, Kirkwood, Jm, Eggermont, Amm, Dreno, B, Nolop, K, Li, J, Nelson, B, Hou, J, Lee, Rj, Flaherty, Kt, Mcarthur, Ga, BRIM-3 Study Group, Cognetti, F
Publikováno v:
New England Journal of Medicine, 364(26), 2507-2516. Massachussetts Medical Society
BACKGROUND Phase 1 and 2 clinical trials of the BRAF kinase inhibitor vemurafenib (PLX4032) have shown response rates of more than 50% in patients with metastatic melanoma with the BRAF V600E mutation. METHODS We conducted a phase 3 randomized clinic
Publikováno v:
van der Veldt, A A M, Boven, E, van den Eertwegh, A J M & Haanen, JB 2009, ' Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer Reply ', British Journal of Cancer, vol. 101, no. 7, pp. 1224-1224 . https://doi.org/10.1038/sj.bjc.6605304
British Journal of Cancer, 101(7), 1224-1224. Nature Publishing Group
British Journal of Cancer, 101(7), 1224-1224. Nature Publishing Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cf417729be6eed6944df185a8a3e6505
https://research.vumc.nl/ws/files/169697/PMC2768095.pdf
https://research.vumc.nl/ws/files/169697/PMC2768095.pdf
Autor:
van Erp NP, Eechoute K, van der Veldt AA, Haanen JB, Reyners AK, Mathijssen RH, Boven E, van der Straaten T, Baak-Pablo RF, Wessels JA, Guchelaar HJ, Gelderblom H, van Erp, Nielka P, Eechoute, Karel, van der Veldt, Astrid A, Haanen, John B, Reyners, An K L, Mathijssen, Ron H J, Boven, Epie, van der Straaten, Tahar
Publikováno v:
Journal of Clinical Oncology; 9/10/2009, Vol. 27 Issue 26, p4406-4412, 7p
Autor:
Leeneman, B, Franken, MG, Jochems, A, Schouwenburg, MG, Wouters, MW, Van den Eertwegh, AJ, Haanen, JB, Van der Hoeven, KJ, Uyl - de Groot, CA
Publikováno v:
In Value in Health November 2015 18(7):A440-A440
Autor:
Leeneman, B, Franken, MG, Jochems, A, Schouwenburg, MG, Wouters, MW, Van den Eertwegh, AJ, Haanen, JB, Van der Hoeven, KJ, Uyl - de Groot, CA
Publikováno v:
In Value in Health November 2015 18(7):A440-A441
Autor:
Leeneman, B, Franken, MG, Jochems, A, Schouwenburg, MG, Wouters, MW, Van den Eertwegh, AJ, Haanen, JB, Van der Hoeven, KJ, Uyl - de Groot, CA
Publikováno v:
Value in Health. (7):A440-A441
Autor:
Leeneman, B, Franken, MG, Jochems, A, Schouwenburg, MG, Wouters, MW, Van den Eertwegh, AJ, Haanen, JB, Van der Hoeven, KJ, Uyl - de Groot, CA
Publikováno v:
Value in Health. (7):A440
Autor:
Leeneman, B1, Franken, MG2, Jochems, A3, Schouwenburg, MG4, Wouters, MW5, Van den Eertwegh, AJ6, Haanen, JB5, Van der Hoeven, KJ3, Uyl - de Groot, CA2, Franken, M G2 (AUTHOR), Schouwenburg, M G4 (AUTHOR), Wouters, M W5 (AUTHOR), Van den Eertwegh, A J6 (AUTHOR), Haanen, J B5 (AUTHOR), Van der Hoeven, K J3 (AUTHOR), Uyl-de Groot, C A2 (AUTHOR)
Publikováno v:
Value in Health. Nov2015, Vol. 18 Issue 7, pA440-A440. 1p.
Autor:
Leeneman, B1, Franken, MG2, Jochems, A3, Schouwenburg, MG4, Wouters, MW5, Van den Eertwegh, AJ6, Haanen, JB5, Van der Hoeven, KJ3, Uyl - de Groot, CA2, Franken, M G2 (AUTHOR), Schouwenburg, M G4 (AUTHOR), Wouters, M W5 (AUTHOR), Van den Eertwegh, A J6 (AUTHOR), Haanen, J B5 (AUTHOR), Van der Hoeven, K J3 (AUTHOR), Uyl-de Groot, C A2 (AUTHOR)
Publikováno v:
Value in Health. Nov2015, Vol. 18 Issue 7, pA440-A441. 1p.
Autor:
Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Sittard-Geleen, The Netherlands., Blank CU; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Bonenkamp JJ; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands., de Groot JB; Isala Oncology Center, Zwolle, The Netherlands., Haanen JB; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Kapiteijn EW; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., de Meza MM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., Stevense-den Boer MAM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, Eindhoven, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Oct 15; Vol. 155 (8), pp. 1455-1465. Date of Electronic Publication: 2024 Jun 24.